Creations of health insurance benefits for NOAC Lixiana

While the use of novel oral anticoagulants(NOAC) has steadily increased, ‘Lixiana’ is expected to be applied by the health insurance benefit.

On the 19^th, the Ministry of Health and Welfare announced it will establish standards and collect opinions for the health insurance benefit of Lixiana, Kapvay ER Tab, an ADHD treatment, and Incruse Ellipta, a chronic obstructive pulmonary disease(COPD), ...